Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Ingrid A. Mayer
Based on 60 articles published since 2008
||||
Expertise Level
The expertise of Ingrid A. Mayer ranks in the
  • Top 0.022%
  • ... of 263,330 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 60 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Vanderbilt University   Contact    
2019
  • From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France · Hospital Universitario 12 de Octubre, Madrid (E.C.) · National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary · German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.) · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan · Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.) · Vanderbilt University, Nashville (I.A.M.) · Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.) · National Taiwan University Hospital, Taipei (Y.-S.L.) · Novartis Pharma, Basel, Switzerland (D.M., C.W.) · Novartis Pharmaceuticals, East Hanover, NJ (S.H.) · and Massachusetts General Hospital Cancer Center, Boston (D.J.). · Pubmed 31091374
  • From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston · Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.) · Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York · University of Colorado Cancer Center, Aurora (J.R.D.) · Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.) · Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.) · Yale University School of Medicine, New Haven, CT (A.D.S.) · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.) · and AIS Consulting, Ann Arbor, MI (A.M.S.). · Pubmed 30786188
  • From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · University of Texas, San Antonio (P.M.R.) · Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O., J.A.) - both in North Carolina · Mayo Clinic, Jacksonville, FL (M.P.G.) · National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L.) · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Washington University, St. Louis (M.J.E.) · the National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and the University of Pittsburgh (A.M.B.), Pittsburgh · Emory University, Atlanta (W.C.W.) · Cancer Trials Ireland, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · and the University of Hawaii Cancer Center, Honolulu (J.L.B.). · Pubmed 31157962
  • Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Departments of Biochemistry, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, 37232-6307, TN, USA. · Departments of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Robert H Lurie Comprehensive Cancer Center, Chicago, 60611, IL, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, 02114, MA, USA. · Baylor University Medical Center, Texas Oncology, , US Oncology, Dallas, 75246, TX, USA. · Guardant Health, Redwood City, 94063, CA, USA. · Novartis Institutes for Biomedical Research, Cambridge, 02139, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, 07936, NJ, USA. · Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Pubmed 30914635
  • Massachusetts General Hospital Cancer Center, Boston, MA · Vanderbilt-Ingram Cancer Center, Nashville, TN. · New York-Presbyterian-Columbia University Irving Medical Center, New York, NY. · Pubmed 31189049
2018
  • Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Oncology, Faculty of Medicine, Laboratory of Experimental Oncology, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Oncology Biomarker Development, Genentech Inc, South San Francisco, CA, USA. · Product Development Oncology, Genentech Inc, South San Francisco, CA, USA. · Clinical Pharmacology, Genentech Inc, South San Francisco, CA, USA. · Biostatistics, Genentech Inc, South San Francisco, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 30185228
  • Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine and Baylor St. Luke's Medical Center, BCM 600, One Baylor Plaza, Houston, TX, 77030, USA. · Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine and Baylor St. Luke's Medical Center, BCM 600, One Baylor Plaza, Houston, TX, 77030, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Vanderbilt University, Nashville, TN, USA. · University of Alabama at Birmingham, Birmingham, AL, USA. · University of Chicago, Chicago, IL, USA. · Mayo Clinic, Rochester, MN, USA. · Houston Methodist Hospital, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 29110152
  • From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina · Mayo Clinic, Jacksonville, FL (M.P.G.) · National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.) · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Washington University, St. Louis (M.J.E.) · National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh · Emory University, Atlanta (W.C.W.) · University of Texas, San Antonio (P.M.R.) · Cancer Trials Ireland, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · and University of Hawaii Cancer Center, Honolulu (J.L.B.). · Pubmed 29860917
2017
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance · UCSF Helen Diller Family Comprehensive Cancer Center · UC San Diego Moores Cancer Center · Dana-Farber/Brigham and Women’s Cancer Center · Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine · University of Colorado Cancer Center · The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute · University of Alabama at Birmingham Comprehensive Cancer Center · The University of Texas MD Anderson Cancer Center · Mayo Clinic Cancer Center · Fox Chase Cancer Center · Massachusetts General Hospital Cancer Center · Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute · Duke Cancer Institute · Vanderbilt-Ingram Cancer Center · Memorial Sloan Kettering Cancer Center · Yale Cancer Center/Smilow Cancer Hospital · University of Wisconsin Carbone Cancer Center · University of Michigan Comprehensive Cancer Center · Fred & Pamela Buffett Cancer Center · Roswell Park Cancer Institute · St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center · The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Research Advocacy Network · Moffitt Cancer Center · City of Hope Comprehensive Cancer Center · Stanford Cancer Institute · Huntsman Cancer Institute at the University of Utah · National Comprehensive Cancer Network · Pubmed 28404755
  • Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. · University Health Network, University of Toronto, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada. · British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Columbia University Medical Center, New York, NY, USA. · National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Allan Blair Cancer Center, Regina, SK, Canada. · British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Pubmed 28447237
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: · Los Angeles Cancer Network, Los Angeles, CA, USA. · Highlands Oncology Group, Fayetteville, AR. · University of California Los Angeles School of Medicine, Los Angeles, CA, USA. · Oncology Consultants PA, Department of Research, Houston, TX, USA. · St Luke's Cancer Institute, Kansas City, MO, USA. · Cancer Treatment Centers of America, Atlanta, GA, USA. · Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA. · UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. · Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA. · Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 28314691
  • Aditya Bardia, Steven J. Isakoff, and Dejan Juric, Massachusetts General Hospital Cancer Center · Aditya Bardia, Steven J. Isakoff, Dejan Juric, and Sara M. Tolaney, Harvard Medical School · Sara M. Tolaney, Dana-Farber Cancer Institute, Boston, MA · Ingrid A. Mayer, Vandana Abramson, and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN · Jennifer R. Diamond and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO · Rebecca L. Moroose and Nikita C. Shah, University of Florida Health Cancer Center, Orlando, FL · Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN · Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center · Joyce O'Shaughnessy, US Oncology, Dallas, TX · Kevin Kalinsky, Columbia University Herbert Irving Comprehensive Cancer Center · Allyson J. Ocean and Linda T. Vahdat, Weill Cornell Medicine, New York, NY · Michael Guarino, Helen F. Graham Cancer Center, Newark, DE · William A. Wegener, Pius Maliakal, Robert M. Sharkey, Serengulam V. Govindan, and David M. Goldenberg, Immunomedics, Morris Plains, NJ. · Pubmed 28291390
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. · University of Virginia Health Sciences Center, Charlottesville, Virginia. · University of Alabama, Birmingham, Alabama. · Methodist Hospital Research Institute, Houston, Texas. · Pubmed 28270498
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Massachusetts General Hospital (MGH), Boston, Massachusetts. · Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Weill Cornell Medical College, New York, New York. · Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts. · Pubmed 27126994
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Instituto Nacional de Enfermedades Neoplásicas, Surquillo 15038, Peru. · Department of Surgery, Emory University, Atlanta, GA 30322, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. · Genoptix Medical Laboratories, Carlsbad, CA 92008, USA. · Foundation Medicine Inc., Cambridge, MA 02141, USA. · Department of Pathology, Albany Medical College, Albany, NY 12208, USA. · Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Pubmed 28794284
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Clinical Medicine, University of Naples Federico II, Naples, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · XenTech, Evry, France. · LTTA Center, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28751448
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Vanderbilt Center for Quantitative Sciences, Department of Statistics, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Divsion of Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. · Veterans Affairs Medical Center, Nashville, TN, USA. · Pubmed 28387221
  • Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee. · Department of Biostatistics, Vanderbilt University, Nashville, Tennessee. · Department of Surgical Oncology, Vanderbilt University, Nashville, Tennessee. · Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, Tennessee. · Pubmed 28003307
2016
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram, Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. · Pubmed 27896521
  • Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, Milan, 20132 Italy. · Department of Medicine Vanderbilt University Medical Center, 1301 Medical Center Drive, TVC Building 4918-A, Nashville, Tennessee 37232, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, 1301 Medical Center Drive, TVC Building 4918-A, Nashville, Tennessee 37232, USA. · Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, 1301 Medical Center Drive, TVC Building 4918-A, Nashville, Tennessee 37232, USA. · Pubmed 27184417
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee 37232; email: , · Pubmed 26473415
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Pubmed 26979397
2015
  • Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA · Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston · Robert G. Mennel, Texas Oncology, Dallas, TX · Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA · Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN · David G. Hicks, University of Rochester Medical Center, Rochester, NY · Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC · Wanda Lucas, Georgetown University, Washington, DC · Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN · and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH. · Pubmed 26195705
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute · Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA · Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN · Carla I. Falkson, University of Alabama, Birmingham, AL · Timothy J. Hobday, Mayo Clinic, Rochester, MN · E. Claire Dees, University of North Carolina, Chapel Hill, NC · Rita Nanda, University of Chicago, Chicago, IL · Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX · and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG) · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC) · NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG) · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL) · Columbia University Medical Center, New York, NY (DLH) · National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR) · Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM) · Mayo Clinic College of Medicine, Rochester, MN (TJH) · Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL) · National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT) · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP) · Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM) · Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC) · British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO) · University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST) · British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB) · Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS). · Pubmed 25740979
  • From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina · Mayo Clinic, Jacksonville, FL (E.A.P.) · University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas · Washington University, St. Louis (M.J.E.) · Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh · the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.) · Emory University, Atlanta (W.C.W.) · Irish Clinical Oncology Research Group, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · University of Hawaii Cancer Center, Honolulu (J.L.B.) · and Stanford University, Stanford, CA (G.W.S.) · Pubmed 26412349
  • Presented by Ingrid A. Mayer, MD, MSCI, Associate Professor of Medicine and Clinical Director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Pubmed 25995422
2014
  • Vanderbilt University School of Medicine, Nashville, TN. · Pubmed 25658890
  • Authors' Affiliations: Departments of Medicine and Cancer Biology; and Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 24536073
  • Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN · Steven J. Isakoff, Massachusetts General Hospital, Boston, MA · Andres Forero, University of Alabama, Birmingham, AL · Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT · Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA · Yisheng Li, MD Anderson Cancer Center, Houston, TX · and Lewis C. Cantley, Weill Cornell Medical College, New York, NY. · Pubmed 24663045
  • Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA · Pubmed 24797823
2013
  • Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Pubmed 24896546
2015
  • From Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Washington/Seattle Cancer Care Alliance; UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Colorado Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Mayo Clinic Cancer Center; Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; Roswell Park Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Research Advocacy Network; Moffitt Cancer Center; City of Hope Comprehensive Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26656517
  • Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Pubmed 26008918
  • From the *Institute of Imaging Science, †Department of Radiology and Radiological Sciences, ‡the Vanderbilt-Ingram Cancer Center, Departments of §Biostatistics, ∥Radiation Oncology, ¶Medical Oncology, #Surgical Oncology, **Pathology, ††Physics and Astronomy, ‡‡Cancer Biology, and §§Biomedical Engineering, Vanderbilt University, Nashville, TN. · Pubmed 25360603
2014
  • Vanderbilt University Institute of Imaging Science (VUIIS), Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 23661583
2013
  • Vanderbilt University Medical Center, Nashville, Tennessee 37203-1738, USA. · Pubmed 23575918
  • Department of Internal Medicine, Vanderbilt University Medical Center, D-3100 Medical Center North, Nashville, TN 37232-2358, USA. · Pubmed 23564368
2012
  • Vanderbilt University Medical Center, 2200 Pierce Ave, 777 PRB, Nashville, TN 37232-6307, USA. · Pubmed 22879364
  • Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee 37232-2310, USA. · Pubmed 22127821
2011
  • Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, TN 37212, USA. · Pubmed 21918859
  • Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21841212
  • Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21509862
2010
  • Department of Medicine and Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 20587404
Probable:    Duke-NUS Medical School      
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
Probable:    Peter MacCallum Cancer Centre      
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 60 total) written by Ingrid A. Mayer about Breast Neoplasms:

  • Alpelisib for 2019
  • Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer. 2019
  • Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. 2019
  • Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. 2019
  • Sacituzumab Govitecan-hziy in Triple-Negative Breast Cancer. Reply. 2019
  • A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer. 2018
  • Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. 2018
  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. 2018
  • NCCN Guidelines Insights: Breast Cancer, Version 1.2017. 2017
  • Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32. 2017
Show List of Full Article Records
Google Searches

Learn more about Ingrid A. Mayer using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Vanderbilt University
Duke-NUS Medical School
Peter MacCallum Cancer Centre
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Vanderbilt University
2019
  • From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France · Hospital Universitario 12 de Octubre, Madrid (E.C.) · National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary · German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.) · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan · Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.) · Vanderbilt University, Nashville (I.A.M.) · Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.) · National Taiwan University Hospital, Taipei (Y.-S.L.) · Novartis Pharma, Basel, Switzerland (D.M., C.W.) · Novartis Pharmaceuticals, East Hanover, NJ (S.H.) · and Massachusetts General Hospital Cancer Center, Boston (D.J.). · Pubmed 31091374
  • From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston · Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.) · Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York · University of Colorado Cancer Center, Aurora (J.R.D.) · Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.) · Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.) · Yale University School of Medicine, New Haven, CT (A.D.S.) · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.) · Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.) · and AIS Consulting, Ann Arbor, MI (A.M.S.). · Pubmed 30786188
  • From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · University of Texas, San Antonio (P.M.R.) · Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O., J.A.) - both in North Carolina · Mayo Clinic, Jacksonville, FL (M.P.G.) · National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L.) · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Washington University, St. Louis (M.J.E.) · the National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and the University of Pittsburgh (A.M.B.), Pittsburgh · Emory University, Atlanta (W.C.W.) · Cancer Trials Ireland, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · and the University of Hawaii Cancer Center, Honolulu (J.L.B.). · Pubmed 31157962
  • Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Departments of Biochemistry, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, 37232-6307, TN, USA. · Departments of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Robert H Lurie Comprehensive Cancer Center, Chicago, 60611, IL, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, 02114, MA, USA. · Baylor University Medical Center, Texas Oncology, , US Oncology, Dallas, 75246, TX, USA. · Guardant Health, Redwood City, 94063, CA, USA. · Novartis Institutes for Biomedical Research, Cambridge, 02139, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, 07936, NJ, USA. · Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Pubmed 30914635
  • Massachusetts General Hospital Cancer Center, Boston, MA · Vanderbilt-Ingram Cancer Center, Nashville, TN. · New York-Presbyterian-Columbia University Irving Medical Center, New York, NY. · Pubmed 31189049
2018
  • Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Oncology, Faculty of Medicine, Laboratory of Experimental Oncology, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium. · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Oncology Biomarker Development, Genentech Inc, South San Francisco, CA, USA. · Product Development Oncology, Genentech Inc, South San Francisco, CA, USA. · Clinical Pharmacology, Genentech Inc, South San Francisco, CA, USA. · Biostatistics, Genentech Inc, South San Francisco, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 30185228
  • Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine and Baylor St. Luke's Medical Center, BCM 600, One Baylor Plaza, Houston, TX, 77030, USA. · Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine and Baylor St. Luke's Medical Center, BCM 600, One Baylor Plaza, Houston, TX, 77030, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Vanderbilt University, Nashville, TN, USA. · University of Alabama at Birmingham, Birmingham, AL, USA. · University of Chicago, Chicago, IL, USA. · Mayo Clinic, Rochester, MN, USA. · Houston Methodist Hospital, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 29110152
  • From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina · Mayo Clinic, Jacksonville, FL (M.P.G.) · National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.) · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Washington University, St. Louis (M.J.E.) · National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh · Emory University, Atlanta (W.C.W.) · University of Texas, San Antonio (P.M.R.) · Cancer Trials Ireland, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · and University of Hawaii Cancer Center, Honolulu (J.L.B.). · Pubmed 29860917
2017
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance · UCSF Helen Diller Family Comprehensive Cancer Center · UC San Diego Moores Cancer Center · Dana-Farber/Brigham and Women’s Cancer Center · Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine · University of Colorado Cancer Center · The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute · University of Alabama at Birmingham Comprehensive Cancer Center · The University of Texas MD Anderson Cancer Center · Mayo Clinic Cancer Center · Fox Chase Cancer Center · Massachusetts General Hospital Cancer Center · Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute · Duke Cancer Institute · Vanderbilt-Ingram Cancer Center · Memorial Sloan Kettering Cancer Center · Yale Cancer Center/Smilow Cancer Hospital · University of Wisconsin Carbone Cancer Center · University of Michigan Comprehensive Cancer Center · Fred & Pamela Buffett Cancer Center · Roswell Park Cancer Institute · St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center · The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Research Advocacy Network · Moffitt Cancer Center · City of Hope Comprehensive Cancer Center · Stanford Cancer Institute · Huntsman Cancer Institute at the University of Utah · National Comprehensive Cancer Network · Pubmed 28404755
  • Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. · University Health Network, University of Toronto, Toronto, ON, Canada. · Canadian Cancer Trials Group (CCTG), Cancer Research Institute, Queen's University, Kingston, ON, Canada. · British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Dana-Farber Cancer Institute, Boston, MA, USA. · Columbia University Medical Center, New York, NY, USA. · National Surgical Adjuvant Breast and Bowel Project and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Centre Hospitalier Universitaire de Québec, Quebec, QC, Canada. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, ON, Canada. · Juravinski Cancer Centre, Hamilton, ON, Canada. · Allan Blair Cancer Center, Regina, SK, Canada. · British Columbia Cancer Agency, Vancouver Island Center, University of British Columbia, Vancouver, BC, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Medicine, Division of Medical Oncology and Hematology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, 1284-600 University Ave, Toronto, ON, M5G 1X5, Canada. · Department of Medicine, Division of Clinical Epidemiology, University of Toronto, Toronto, ON, Canada. · Pubmed 28447237
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. Electronic address: · Los Angeles Cancer Network, Los Angeles, CA, USA. · Highlands Oncology Group, Fayetteville, AR. · University of California Los Angeles School of Medicine, Los Angeles, CA, USA. · Oncology Consultants PA, Department of Research, Houston, TX, USA. · St Luke's Cancer Institute, Kansas City, MO, USA. · Cancer Treatment Centers of America, Atlanta, GA, USA. · Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA. · UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA, USA. · Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN, USA. · Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center, Baltimore, MD, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 28314691
  • Aditya Bardia, Steven J. Isakoff, and Dejan Juric, Massachusetts General Hospital Cancer Center · Aditya Bardia, Steven J. Isakoff, Dejan Juric, and Sara M. Tolaney, Harvard Medical School · Sara M. Tolaney, Dana-Farber Cancer Institute, Boston, MA · Ingrid A. Mayer, Vandana Abramson, and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN · Jennifer R. Diamond and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO · Rebecca L. Moroose and Nikita C. Shah, University of Florida Health Cancer Center, Orlando, FL · Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN · Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center · Joyce O'Shaughnessy, US Oncology, Dallas, TX · Kevin Kalinsky, Columbia University Herbert Irving Comprehensive Cancer Center · Allyson J. Ocean and Linda T. Vahdat, Weill Cornell Medicine, New York, NY · Michael Guarino, Helen F. Graham Cancer Center, Newark, DE · William A. Wegener, Pius Maliakal, Robert M. Sharkey, Serengulam V. Govindan, and David M. Goldenberg, Immunomedics, Morris Plains, NJ. · Pubmed 28291390
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. · University of Virginia Health Sciences Center, Charlottesville, Virginia. · University of Alabama, Birmingham, Alabama. · Methodist Hospital Research Institute, Houston, Texas. · Pubmed 28270498
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Massachusetts General Hospital (MGH), Boston, Massachusetts. · Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Weill Cornell Medical College, New York, New York. · Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts. · Pubmed 27126994
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Instituto Nacional de Enfermedades Neoplásicas, Surquillo 15038, Peru. · Department of Surgery, Emory University, Atlanta, GA 30322, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. · Genoptix Medical Laboratories, Carlsbad, CA 92008, USA. · Foundation Medicine Inc., Cambridge, MA 02141, USA. · Department of Pathology, Albany Medical College, Albany, NY 12208, USA. · Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Pubmed 28794284
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Clinical Medicine, University of Naples Federico II, Naples, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · XenTech, Evry, France. · LTTA Center, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28751448
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Vanderbilt Center for Quantitative Sciences, Department of Statistics, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. · Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. · Divsion of Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. · Veterans Affairs Medical Center, Nashville, TN, USA. · Pubmed 28387221
  • Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee. · Department of Biostatistics, Vanderbilt University, Nashville, Tennessee. · Department of Surgical Oncology, Vanderbilt University, Nashville, Tennessee. · Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, Tennessee. · Pubmed 28003307
2016
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram, Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. · Pubmed 27896521
  • Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, Milan, 20132 Italy. · Department of Medicine Vanderbilt University Medical Center, 1301 Medical Center Drive, TVC Building 4918-A, Nashville, Tennessee 37232, USA. · Department of Cancer Biology, Vanderbilt University Medical Center, 1301 Medical Center Drive, TVC Building 4918-A, Nashville, Tennessee 37232, USA. · Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, 1301 Medical Center Drive, TVC Building 4918-A, Nashville, Tennessee 37232, USA. · Pubmed 27184417
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee 37232; email: , · Pubmed 26473415
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Pubmed 26979397
2015
  • Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA · Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston · Robert G. Mennel, Texas Oncology, Dallas, TX · Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA · Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN · David G. Hicks, University of Rochester Medical Center, Rochester, NY · Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC · Wanda Lucas, Georgetown University, Washington, DC · Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN · and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH. · Pubmed 26195705
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute · Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA · Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN · Carla I. Falkson, University of Alabama, Birmingham, AL · Timothy J. Hobday, Mayo Clinic, Rochester, MN · E. Claire Dees, University of North Carolina, Chapel Hill, NC · Rita Nanda, University of Chicago, Chicago, IL · Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX · and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG) · NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC) · NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG) · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL) · Columbia University Medical Center, New York, NY (DLH) · National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR) · Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM) · Mayo Clinic College of Medicine, Rochester, MN (TJH) · Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL) · National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT) · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP) · Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM) · Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC) · British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO) · University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST) · British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB) · Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS). · Pubmed 25740979
  • From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.) · Dana-Farber Cancer Institute, Boston (R.J.G.) · Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada · Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois · University of Michigan, Ann Arbor (D.F.H.) · Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.) · University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina · Mayo Clinic, Jacksonville, FL (E.A.P.) · University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland · Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis · Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin · Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas · Washington University, St. Louis (M.J.E.) · Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh · the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.) · Emory University, Atlanta (W.C.W.) · Irish Clinical Oncology Research Group, Dublin (M.M.K.) · Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.) · Cancer Center of Kansas, Wichita (P.S.R.) · Vanderbilt University, Nashville (I.A.M.) · Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.) · University of Hawaii Cancer Center, Honolulu (J.L.B.) · and Stanford University, Stanford, CA (G.W.S.) · Pubmed 26412349
  • Presented by Ingrid A. Mayer, MD, MSCI, Associate Professor of Medicine and Clinical Director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Pubmed 25995422
2014
  • Vanderbilt University School of Medicine, Nashville, TN. · Pubmed 25658890
  • Authors' Affiliations: Departments of Medicine and Cancer Biology; and Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 24536073
  • Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN · Steven J. Isakoff, Massachusetts General Hospital, Boston, MA · Andres Forero, University of Alabama, Birmingham, AL · Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT · Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA · Yisheng Li, MD Anderson Cancer Center, Houston, TX · and Lewis C. Cantley, Weill Cornell Medical College, New York, NY. · Pubmed 24663045
  • Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA · Pubmed 24797823
2013
  • Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Pubmed 24896546
2015
  • From Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Washington/Seattle Cancer Care Alliance; UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Colorado Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Mayo Clinic Cancer Center; Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; Roswell Park Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Research Advocacy Network; Moffitt Cancer Center; City of Hope Comprehensive Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network. · Pubmed 26656517
  • Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Pubmed 26008918
  • From the *Institute of Imaging Science, †Department of Radiology and Radiological Sciences, ‡the Vanderbilt-Ingram Cancer Center, Departments of §Biostatistics, ∥Radiation Oncology, ¶Medical Oncology, #Surgical Oncology, **Pathology, ††Physics and Astronomy, ‡‡Cancer Biology, and §§Biomedical Engineering, Vanderbilt University, Nashville, TN. · Pubmed 25360603
2014
  • Vanderbilt University Institute of Imaging Science (VUIIS), Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 23661583
2013
  • Vanderbilt University Medical Center, Nashville, Tennessee 37203-1738, USA. · Pubmed 23575918
  • Department of Internal Medicine, Vanderbilt University Medical Center, D-3100 Medical Center North, Nashville, TN 37232-2358, USA. · Pubmed 23564368
2012
  • Vanderbilt University Medical Center, 2200 Pierce Ave, 777 PRB, Nashville, TN 37232-6307, USA. · Pubmed 22879364
  • Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee 37232-2310, USA. · Pubmed 22127821
2011
  • Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, TN 37212, USA. · Pubmed 21918859
  • Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21841212
  • Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21509862
2010
  • Department of Medicine and Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 20587404
Duke-NUS Medical School
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
Peter MacCallum Cancer Centre
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
29 Other Locations Show
Yearly article counts 53126108545200
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.